EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy

Hassan Abdelilah Tafenzi, Ismail Essadi, Rhizlane Belbaraka

Journal of the National Cancer Center · 2026-08 · 6 (4) · 329-344

DOI: 10.1016/j.jncc.2026.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Cancer Center, 2026-08. Verfasst von Hassan Abdelilah Tafenzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco. Die Arbeit nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Consolidation therapyNon-small cell lung cancerStage IIIUnresectable

Autor:innen und Institutionen

  • Medical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.
  • Biosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
  • Medical Oncology Department, Avicenna Military Hospital of Marrakech, Marrakech, Morocco.

Zitieren

APA

Tafenzi, H. A., Essadi, I., & Belbaraka, R. (2026). Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy. Journal of the National Cancer Center, 6(4), 329-344. https://doi.org/10.1016/j.jncc.2026.04.006

Vancouver

Tafenzi HA, Essadi I, Belbaraka R. Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy. Journal of the National Cancer Center. 2026;6(4):329-344. doi:10.1016/j.jncc.2026.04.006

BibTeX
@article{Tafenzi2026,
  author = {Tafenzi, Hassan Abdelilah and Essadi, Ismail and Belbaraka, Rhizlane},
  title = {Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy},
  journal = {Journal of the National Cancer Center},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {329--344},
  doi = {10.1016/j.jncc.2026.04.006}
}
Kostenlos starten →